About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, June 25th, 2013

The QualityStocks
Daily Stock List

graphic
graphic

Del Toro Silver Corp. (DTOR)

RedChip reported recently on Del Toro Silver Corp. (DTOR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 2006, Del Toro Silver Corp. is a mining and exploration company based in Carson City, Nevada. Their strategy is to focus on the acquisition and development of high grade, near term production gold properties in California and elsewhere in the Western U.S. The Company previously went by the name Candev Resource Exploration, Inc. They changed their name to Del Toro Silver Corp. in August of 2009. Del Toro’s shares trade on the OTC Market’s OTCQB.

The Company’s target properties will require limited exploration, development and mining expenditures. They will have the potential for near term production and positive cash flow. Del Toro Silver’s goal is to become a gold producer and industry leader in the small to mid size mine market.

On April 1, 2013 Del Toro Silver announced that, on March 8, 2013, the Company signed a Joint Venture Partnership Terms Agreement with Noble Mining, Inc. pertaining to the development of a prospective toll milling facility in the western U.S. Under this agreement, Noble Mining will provide financing of up to $6,000,000 for the acquisition, development, permitting and operating capital for the toll milling partnership.

Del Toro Silver will be responsible for securing and delivering the toll milling facility and obtaining the necessary permitting to process ore. They will also be responsible for locating and contracting customers to process ore through the toll mill, and managing day to day operations of the toll mill.

Last week, Del Toro Silver announced that on June 6, 2013, they executed a Purchase Option Termination agreement with Natchez Pass, LLC to terminate the August 31, 2012 Partial Purchase Option Agreement. The Termination Agreement provides the Company with a 5 percent Net Smelter Royalty (NSR) on production from the Natchez Pass Gold Property (the "Nick").

Del Toro Silver renegotiated the terms for their participation in the property so additional private equity could be invested into Natchez Pass LLC on more favorable terms than might otherwise be available. This capital infusion will be used to replace the existing reclamation bond, complete mill upgrades, and drill a new water well. This will enable operation of the mine. The work plan has been put into action. The expectation is that placer mining will start within the next 30 days.

Del Toro Silver Corp. (DTOR), closed Tuesday’s trading session at $0.07, even for the day, on 26,155 volume with 9 trades. The average volume for the last 60 days is 102,076 and the stock's 52-week low/high is $0.0193/$0.15.

Sierra Resource Group, Inc. (SIRG)

OTCPicks reported previously on Sierra Resource Group, Inc. (SIRG), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Based in Las Vegas, Nevada, Sierra Resource Group, Inc. is a mining enterprise whose commitment is to the exploration, discovery and development of gold, silver, copper, and other mineral resources. Looking to expand throughout the Americas, the Company currently holds mining properties and mineral claims in Arizona. Sierra's primary asset was 90 percent ownership of the Chloride Copper Mine situated near Kingman, Arizona. They subsequently acquired the remaining 10 percent minority interest and now own 100 percent of the Mine. 

The technical report, NI43-101, by Scott Wilson Roscoe Postle Associates March 10, 2006, estimates the Chloride Copper Mine contains 27,000,000 pounds of copper. Sierra’s intention is to use open pit mining and they plan to reopen the existing SX/EW plant on site with a maximum capability of producing up to 5,400,000 pounds of Copper Cathode per year.

The Chloride Copper Mine is located 24 kilometers northwest of Kingman, in the Wallapai District, Mohave County, Arizona, near the town of Chloride. The property consists of 37 unpatented lode mining claims and 12 millsite claims.

An open pit mine and the existing SX/EW processing plant operated at the site from 1995 before being idled in 1996 because of low copper prices. The principal work of Sierra Resource Group is to acquire the necessary funding to bring the Chloride Copper Mine into production so the Company can generate working capital from the operation. 

Earlier this month, Sierra Resource Group announced that they continue to make progress in their efforts to re-open the Chloride Copper Mine. They awarded their Aquifer Protection Permit (APP) work with Arizona Department of Environmental Quality (ADEQ) to full-service engineering and construction firm CDM Smith in August of 2012. Sierra has now additionally engaged CDM Smith for the work associated with their Air Quality Permit (pursuant to the Clean Air Act), and all electrical work associated with building of the substation and all the other electrical needs required to re-start mining operations. 

Sierra Resource Group, Inc. (SIRG), closed Tuesday at $0.003, up 20.00%, on 9,865,600 volume with 18 trades. The average volume for the last 60 days is 334,947 and the stock's 52-week low/high is $0.0001/$0.0127.

Green Energy Renewable Solutions, Inc. (EWRL)

Stockoutlaws, Investor Ideas, Investor Stock Alerts, and OTCPicks reported earlier on Green Energy Renewable Solutions, Inc. (EWRL), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

USA Market News, Fast Moving Stocks, MicrocapVoice, Top Gun, TooNiceStocks, The Stock Psycho, and PennyStockCrowd reported earlier on Green Energy Renewable Solutions, Inc. (EWRL), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Green Energy Renewable Solutions, Inc. is a developer of municipal solid waste and construction and demolition waste processing and recycling facilities. Their intention is to process and recycle waste materials; and create energy from waste products. A development stage company, they operate with long-term supply agreements to process waste materials into valuable recyclables (primarily metal, plastic, cardboard, asphalt, and wood) and reduce waste volume going into landfills by up to 80 percent. The Company has their headquarters in Detroit, Michigan.

In addition, Green Energy has developed a strategic plan to create sustainable renewable energy with waste-to-energy power plants and the production of waste derived fuels.

Last month, Green Energy Renewable Solutions announced that they merged with Cirque Energy II, LLC.  Cirque Energy is a privately-owned renewable energy development company based in Ithaca, Michigan. Cirque Energy has specific expertise and extensive experience in the development, design, financing, construction, and operation of landfill operations, renewable energy and traditional distributed generation power projects.

Cirque develops, builds, and operates small to midsize renewable energy power plants utilizing gasification technology. This provides new base-load energy demands with sustainable energy solutions. The Company’s focus includes working with industrial clients to develop solutions to provide long-term predictable costs of energy, while maximizing energy efficiency through the use of combined heat and power (CHP) systems.

Green Energy’s plan is to change their name to Cirque Energy, Inc. They intend to apply for a new trading symbol. They will continue to trade under their present symbol, EWRL (OTC Markets’ OTCQB), until they’re assigned a new trading symbol.

Furthermore, in May, Green Energy Renewable Solutions announced that the United States Bankruptcy Court for the Eastern District of Michigan confirmed the Company as the sole bidder to acquire the Davison Landfill assets of Richfield Equities, LLC. Richfield Equities is a privately-owned waste management company. Richfield Equities voluntarily filed for bankruptcy protection under Chapter 11 on September 18, 2012.

The Davison Landfill is in Davison, Michigan, approximately ten miles southeast of Flint, Michigan (Genesee County). It is the state’s second largest landfill, as defined by available airspace. It has almost 400 acres and 28 million cubic yards of available airspace. The Davison Landfill offers a useful life expectancy of greater than 35 years at current projected disposal levels.

Green Energy Renewable Solutions, Inc. (EWRL), closed at $0.0125, up 56.25%, on 9,784,669 volume with 113 trades. The average volume for the last 60 days is 2,195,173 and the stock's 52-week low/high is $0.002/$0.44.

Homeland Resources Ltd. (HMLA)

Market Authority reported yesterday on Homeland Resources Ltd. (HMLA), The Stock Enthusiast, PennyStocks24, UltimatePennyStock, YOLOTraderAlerts, Todd Horwitz, The Trading Report, Oakshire Financial, Trade of the Week, StreetAuthority Financial, Oakshire News Bulletin, Investors Alley, Wyatt Investment Research did earlier, and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Founded in 2003, Homeland Resources Ltd. is an emerging oil and gas exploration and production company. Listed on the OTC Markets’ OTCQB, the Company is focusing on developing relatively low-risk North American natural gas reserves. Among their projects is a large multi-well program based in south central Oklahoma. Homeland Resources has their headquarters in Albuquerque, New Mexico.

The Company’s current focus is on the continued exploration and development of their property portfolio consisting of working interests in the Smoky Hill Project (5 percent interest) and the Liberty Ridge Project (5 percent interest) in Oklahoma. In addition, Homeland Resources is also looking to expand their portfolio to include additional interests in North America.

The Smoky Hill Production Program is in south-central Oklahoma; it involves three wells (the Marshall, the Bradley, and the Patton). These are Basal Oil Creek Sand targets - one has a second Bromide Sand objective. Expected total program reserves to be developed in this project could be in the range of 750,000 BO and 0.15 BCFG. The first well in this prospect, the Patton-1, is a production well, which generates monthly revenues for Homeland Resources.

The Liberty Ridge project is a multi-well multi-phase exploration drill program. The program is currently being conducted by Homeland and their partners. The Phase-1 drilling program at Liberty Ridge consists of eight wells selected from at least 34 distinct high-graded prospects generated by the partnership's proprietary 3D seismic database covering the entire 83,043 acres (130 square miles) project area. Drilling at the Liberty Ridge project is expected to continue throughout 2013-2014.

Yesterday, Homeland Resources announced the next two spud dates for drilling at the Liberty Ridge Oil and Gas Project in Oklahoma. They and their partners have determined that well #2 will be spud on July 1, 2013 and well #3 will be spud on July 6, 2013. The expectation is that the new wells will target two separate high priority exploration prospects as part of the ongoing eight well Phase-1 drill program now underway at Liberty Ridge.

Homeland Resources Ltd. (HMLA), closed Tuesday’s trading at $0.145, up 3.57%, on 473,519 volume with 61 trades. The average volume for the last 60 days is 143,419 and the stock's 52-week low/high is $0.05/$0.27.

Medicago, Inc. (MDCGF)

IRGnews Alert reported previously on Medicago, Inc. (MDCGF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Medicago, Inc. focuses on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs). The Company is a clinical-stage biopharmaceutical enterprise developing novel vaccines and therapeutic proteins to address a wide spectrum of infectious diseases globally.

Medicago’s shares trade on the OTCQX International. The Company is based in Quebec City, Quebec. Medicago operates a 24,000-square-foot production facility located in the Technology Park in Quebec City. This facility includes a Biosafety level 2 greenhouse and an extraction and purification unit; it is cGMP compliant.

Medicago U.S.A. is a wholly owned subsidiary of Medicago. Medicago U.S.A. has completed the construction of their facility (97,000-square-foot cGMP facility) in Research Triangle Park (RTP), North Carolina. This Virus-Like-Particle plant-based vaccine facility includes a fully automated greenhouse and a state of the art extraction and purification unit. The facility is targeted to produce 10 million doses of pandemic influenza vaccine monthly. On an annual basis, the facility could have production capacity of 30 million doses of quadrivalent seasonal influenza vaccine or 120 million doses of pandemic influenza vaccine.

Medicago is a leader in the development of VLP vaccines by means of a transient expression system that produces recombinant vaccine antigens in plants. The Company indicates that this technology has the potential to offer more potent vaccines with speed and cost advantages over competitive technologies, enabling the development of a vaccine for testing in approximately one month after the identification and reception of genetic sequences from a pandemic strain.

This production time frame has the potential to permit vaccination of the population before the first wave of a pandemic, and supply great volumes of vaccine antigens to the global market. Moreover, the Company’s intention is to expand development into other areas for example biosimilars and biodefense products.

Medicago's pipeline includes the development of their Rotavirus VLP vaccine, and a Phase II pandemic readiness clinical trial for their H5N1 pandemic influenza vaccine with interim data expected in the second half of this year. Additionally, their pipeline includes a U.S. Phase IIa clinical trial for a quadrivalent seasonal flu vaccine with interim data expected in the second half of 2013 as well. Medicago is conducting ongoing GMP process development for a rabies vaccine, and research and development in the area of biosimilar products.

Last week, Medicago announced the successful production of a Rotavirus VLP vaccine candidate consisting of all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using the Company’s plant-based manufacturing platform. They additionally announced that an international patent application under the Patent Cooperation Treaty (PCT) that broadly covers plant-produced Rotavirus VLPs was filed.

Medicago, Inc. (MDCGF), closed Tuesday’s trading session at $0.7464, up 3.67%, on 18,500 volume with 10 trades. The average volume for the last 60 days is 13,675 and the stock's 52-week low/high is $0.354/$0.76.

United Health Products, Inc. (UEEC)

XplosiveStocks, CRWEWallStreet, CRWEFinance, and Stock Guru reported previously on United Health Products, Inc. (UEEC), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, United Health Products, Inc. is a product development and solutions company. The Company is focusing their growth initiatives on the expanding wound-care industry and the disposable medical supplies markets. Epic Wound Care, Inc. is their principal operating subsidiary. Epic produces a unique gauze product that absorbs exudate (fluids that have been discharged from blood vessels) by forming a gel-like substance upon contact.

United Health Products has their headquarters in Colts Neck, New Jersey. They service their customers by way of distributors, sales representatives, industry-specialized telephone support, and the Internet.

The Company’s Epic Wound Care produces hemostatic gauze. This is a collagen-like natural substance created from chemically treated cellulose. The design of it is to address severe bleeding in wound care applications. United Health Products is focusing on identifying additional emerging healthcare products and technologies, chiefly hemostatic, for strategic partnership or acquisition.

In March of this year, United Health Products announced that wholly owned subsidiary; Epic Wound Care was recognized as a vendor/supplier by the Church of Jesus Christ of Latter Day Saints (LDS). United Health Products provided LDS with initial orders of their HemoStyp™ Gauze that is being incorporated into aid packages for Humanitarian Relief and Assistance.

HemoStyp™ is specially formulated gauze; it will produce hemostasis almost instantly upon application to a cut or open wound. HemoStyp™ contains no harmful chemicals, thrombin, or animal by-products; it is easily removed from the wound with water or saline solution without compromising coagulation. HemoStyp’s™ inherent bacteriostatic properties are also effective for contaminated wounds where it is difficult to maintain a sterile field.

HemoStyp™ is FDA registered. It controls several types of bleeding. These include Arterial, Veinal, and Capillary Injuries; Post Dialysis Treatment; Nose Bleeds; Abrasions, Lacerations, and Major Cuts; Dental Surgeries; and Puncture Wounds. The Company’s technology is marketed as HemoStyp™ Gauze. However, it is also available to customers with customized private labeling.

United Health Products, Inc. (UEEC), closed Tuesday’s trading session at $0.165, down 1.20%, on 256,000 volume with 22 trades. The average volume for the last 60 days is 161,284 and the stock's 52-week low/high is $0.0206/$0.20.

Great Quest Metals Ltd. (GQ.V)

Today we are reporting on Great Quest Metals Ltd. (GQ.V), here at the QualityStocks Daily Newsletter.

Great Quest Metals Ltd. is a mineral exploration company with assets in Mali, West Africa. Listed on the TSX Venture Exchange, the Company is focusing on developing the Tilemsi Phosphate Project, covering 1,206 km² in eastern Mali. In addition, they hold a number of gold concessions in the productive Birimian gold belt, in southwestern Mali. Great Quest Metals has their corporate headquarters in Vancouver, British Columbia.

Concerning the Tilemsi Phosphate Project, to date, Great Quest Metals has published two resource reports with the total inferred resource now standing at 50 million tonnes at an average grade of 24.3 percent P₂O₅ (at 10 percent cut-off). Phosphate rock from the Tilemsi Project displayed good characteristics for effective beneficiation with assays ranging between 25 percent and 38 percent P₂O₅, and a low level of contaminants, particularly Cadmium.

Phosphates are the naturally occurring form of the element phosphorus, a primary, nutrient-rich element vital for crop growth. It cannot be manufactured or replaced. Phosphorus has several commercial uses in manufacturing and everyday products. However, it is most important as a component of fertilizers.

Great Quest Metals development plans include the production of two granulated phosphate fertilizers. One is a high grade for mixture into standard NPK blends. The other is a medium grade for simple and low cost direct application.

The Company, despite the current political situation in Mali since the March 2012 coup, continues to advance their project through the engineering test work and economic analysis undertaken by their South Africa-based contractor. Great Quest Metals has an office in Bamako and maintains their plans to resume work on the ground as soon as the situation permits.

Last week, Great Quest Metals congratulated Mali on the 'Historic' Kidal Agreement. Mali's government signed a ceasefire agreement with the secular Tuareg MNLA rebels. The new accord allows the Malian authority and their army to return to Kidal, the rebels' final stronghold in northeastern Mali.

This is a major step for Mali's crisis recovery process; it removes the last obstacle on the path to countrywide elections scheduled for July 28, 2013. It also paves the way for a lasting peace in the country's northern region. Great Quest remains committed to bringing the Tilemsi Phosphate project into production. Their intention is to resume their exploration program in Tilemsi soon after the elections.

Great Quest Metals Ltd. (GQ.V), closed Tuesday’s trading session at $0.68, even for the day, on 4,000 volume. The stock's 52-week low/high is $0.43/$1.38.

Verisante Technology, Inc. (VRSEF)

RedChip reported recently on Verisante Technology, Inc. (VRSEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Vancouver, British Columbia, Verisante Technology, Inc. is a medical device company.  Their commitment is to commercializing unique systems for the early detection of cancer. Their exclusive platform technology allows them to develop and offer a variety of compact, non-invasive cancer detection devices that offer immediate results for many of the most common cancers.

The Verisante Aura™ for skin cancer detection and the Verisante Core™ series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform. The operating software and probe technology are unique to each device. The BC Cancer Agency developed the cancer detection platform. The platform was tested and refined at the Skin Care Centre at Vancouver General Hospital.  

Aura™ has received approval for sale in Canada, Europe and Australia. The Core™ has not yet received approval for sale. Verisante Aura™ was awarded Popular Science Magazine's "Best of What's New Award" for 2011. It was also awarded a 2013 Prism Award for Innovation in Photonics. Verisante Core™ was named one of the top 10 cancer breakthroughs of 2011 by the Canadian Cancer Society. 

Verisante Aura™ is indicated for use for the evaluation of skin lesions that may be clinically suspicious for melanoma, squamous cell carcinoma and/or basal cell carcinoma when a medical professional chooses to obtain more information to rule out one of the above conditions before making a final decision to biopsy. Aura™ is a non-invasive optical system. It utilizes Raman spectroscopy to biochemically analyze the skin, providing immediate results.

This month, Verisante Technology announced that they entered into an exclusive agreement with Frontière Médicale EUROPE LLC, to distribute Verisante Aura™ in the UK and Ireland. Frontière Médicale, based in London and Paris, specializes in the distribution of new technologies via rapid market access through strategic market entry.

For the first quarter ended March 31, 2013, Verisante Technology had their first revenues from the sale of Aura™ recognized, as well as official product launches for Aura™ in Canada and Germany. They also had placement of Aura™ units in clinics with key opinion leaders across Canada in Vancouver, Edmonton, Calgary, and greater Toronto. For the three months ended March 31, 2013, the Company recognized revenue of $235,000 compared to $0 reported for the same period in 2012.

Verisante Technology, Inc. (VRSEF), closed Tuesday’s trading session at $0.3134, up 0.90%, on 91,615 volume with 13 trades. The average volume for the last 60 days is 37,492 and the stock's 52-week low/high is $0.2791/$0.66.

graphic

The QualityStocks
Company Corner

graphic
graphic

StreamTrack, Inc. (STTK)

The QualityStocks Daily Newsletter would like to spotlight StreamTrack, Inc. (STTK). Today, The Aristocrat Group Corp. closed trading at $0.18, even with yesterday's close, on 134,195 volume with 40 trades. The stock’s average daily volume over the past 60 days is 2,147, and its 52-week low/high is $0.16/$4.80.

StreamTrack, Inc. reported entry today by their subsidiary, StreamTrack Media, Inc., into a two-year licensing agreement with the world's largest radio communications data provider featuring a complete frequency database, trunked radio system information, and FCC license data, RadioReference, LLC. The agreement will see RadioReference utilizing the audio/video streaming and advertising services of the company's RadioLoyalty™ Platform for radio broadcast monetization of over 3,000 licensed stations.

StreamTrack, Inc. (STTK), a digital media and technology services company, provides audio and video streaming and advertising services through its RadioLoyalty™ Platform to a global group of internet and terrestrial radio stations, internet radio guides, and other broadcast content providers. The company's platform powers a web-based and mobile player that manages streaming audio and video content, social media engagement, and ad serving.

StreamTrack offers its platform directly to broadcasters and integrates or white labels its technologies with web-based internet radio guides and other web-based content providers. With StreamTrack technology, broadcasters and publishers are able to maximize their revenue while decreasing expenses, while advertisers are provided with a cost-effective means to reach their target audience from one source at scale.

WatchThis™, StreamTrack's patent-pending technology designed to provide web, mobile, and IP television streaming services that are e-commerce enabled within streamed content, could revolutionize the entertainment industry by combining original network content with interactive product placement. Recognizing the convergence of traditional televised advertisement and internet technology, StreamTrack is advancing its WatchThis™ technology to lead the revolution taking place.

StreamTrack is dedicated to continually creating and managing innovative technology products to provide broadcasters and content owners the most advanced solutions available in the marketplace. Fully committed to also increasing and protecting shareholder value, the management team carefully executes operational, development, and marketing programs with the primary aim of maximizing the company's growth potential and profitability. Disclaimer

StreamTrack, Inc. Company Blog

StreamTrack, Inc. News:

StreamTrack's RadioLoyalty Platform™ Adds Over 3,000 Stations

StreamTrack and One World Media Group Announce Agreement With Monaco Media International

StreamTrack Announces Alliance to Potentially Reach Over 300 Million Registered PPTV Users

Mabwe Minerals Inc. (MBMI)

The QualityStocks Daily Newsletter would like to spotlight Mabwe Minerals Inc. (MBMI). Today, Mabwe Minerals Inc. closed trading at $0.2099, up 74.77%, on 4,238 volume with 2 trades. The stock’s average daily volume over the past 60 days is 230,742, and its 52-week low/high is $0.0056/$0.25.

Mabwe Minerals Inc. (MBMI) is a U.S. based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals, with a particular emphasis on barite. The company's operations are conducted through its Zimbabwe affiliate, Mabwe Mineral Zimbabwe (Private) Ltd. Transitioning into commercial production, MBMI's company fundamentals are well positioned with virtually no debt and key strategic partnerships in place.

Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., an indigenous Zimbabwe company, the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by the company's minority owned partner, WGB Kinsey & Company, Zimbabwe's most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.

The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered "World Class" in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.

With a continuing worldwide shortage of high-grade barite, Mabwe Minerals is in the right place at the right time. The company's current customer uses barite as a weighting agent in oil & gas drilling applications in the Gulf of Mexico, home to the largest concentration of active rigs in the world. Coupled with the recent massive discovery of oil & gas off the coast of neighboring Mozambique along with new drilling contracts expected in the region, MBMI is in an attractive geographical location to capture the expected demands of this emerging market. Moving from an exploration stage company into commercial barite production, Mabwe Minerals is well positioned to generate significant shareholder returns. Disclaimer

Mabwe Minerals Inc. Company Blog

Mabwe Minerals Inc. News:

Mabwe Minerals Inc. Announces Engagement of QualityStocks Investor Relations Services

Mabwe Minerals Shareholder Report Card

Mawbe Minerals Files SEC Form 10-K, Annual Report

GRILLiT, Inc. (GRLT)

The QualityStocks Daily Newsletter would like to spotlight GRILLiT, Inc. (GRLT). Today, GRILLiT, Inc. closed trading at $0.51, up 13.33%, on 4,515 volume with 5 trades. The stock’s average daily volume over the past 60 days is 5,300, and its 52-week low/high is $0.11/$1.50.

GRILLiT, Inc. (GRLT) was founded on the concept of delivering a fast-casual dining experience with fresh, nutritious home-style cooking. Leveraging more than four decades of experience in the food industry, the founders of GRILLiT established this unique business model to satisfy the ever-increasing demand for delicious and healthy food while providing the perfect ambiance for guest to relax and enjoy great cuisine.

The company sources its ingredients from local and domestic farmers to ensure crisp, fresh produce and grain-fed Angus beef. The cooking techniques and low-sodium recipes employed result in uniquely healthy and delectable meal choices. Using the best possible ingredients, GRILLiT chefs have created an inspiring flavor profile using fresh herbs spices and all-natural marinades.

The management team executing GRILLiT’s business strategy has been carefully assembled to achieve rapid growth and profitability. One of the most recent additions, Rob Elliott, brings more than 25 years of experience in restaurant franchise system development, marketing, branding, and operations. Previously serving as Vice President of Marketing for Little Caesars Pizza, he was instrumental in expanding the number of store locations from 150 to 5,000.

GRILLiT is focused on expanding throughout the southeastern United States and offers nationwide franchising opportunities. Current locations operate in high-traffic shopping plazas and offer American, Asian Fusion, and Latin American food styles. The company’s growth strategy is based on a five-year plan to roll out a total of 79 stores in nine States: Florida, Kentucky, Ohio, New Jersey, New Hampshire, North Carolina, Tennessee, Georgia, and Pennsylvania. Disclaimer

GRILLiT, Inc. Company Blog

GRILLiT, Inc. News:

GRILLiT® Brings Top Franchise Branding/PR Firm Aboard

GRILLiT®, Inc. Announces Common Stock Dividend to its Shareholders

GRILLiT®, Inc. Elects Accompplished Restaurant Veteran As Chairman Of Its Board Of Directors

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.24, up 4.35%, on 27,200 volume with 10 trades. The stock’s average daily volume over the past 60 days is 95,586, and its 52-week low/high is $0.161/$0.41.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Subsidiary Lifeline Skin Care Expands Asian Distribution

International Stem Cell Corporation Initiates IND-Enabling Study in Parkinson's Disease Program

International Stem Cell Corporation to Present at Two Upcoming Investor Conferences

StreamTrack, Inc. (STTK) Subsidiary Signs Agreement to Add Over 3,000 Stations

Today before the opening bell, StreamTrack announced that its subsidiary, StreamTrack Media, Inc., has entered into a two-year licensing agreement with RadioReference, LLC.

RadioReference has agreed to utilize the RadioLoyalty Platform™ for radio broadcast monetization of numerous licensed stations. SreamTrack anticipates completing the integration by July 15, 2013. The addition will increase RadioLoyalty Platform’s total count to approximately 5,000 stations.

The world’s largest radio communications data provider, RadioReference features a complete frequency database, trunked radio system information, and FCC license data. The company is also recognized as the largest broadcaster of public safety live audio communications feeds, hosting thousands of live audio broadcasts of Police, Fire, EMS, Railroad, and aircraft communications.

“At the time of this announcement, RadioReference has 3,494 stations that StreamTrack is working to integrate,” StreamTrack’s Chief Executive Officer, Michael Hill, stated. “Under the terms of the license, StreamTrack Media will record 100% of the advertising revenue generated through the RadioLoyalty Platform™ for all 3,494 stations. RadioReference will be paid a flat monthly content fee by StreamTrack Media for supplying the content from the stations. RadioReference will supply unlimited listener caps and bandwidth to support the listening through the RadioLoyalty Platform™.”

For more information, visit www.StreamTrack.com

Cardium Therapeutics, Inc. (CXM) Positioned to Advance Leading Products with Experienced Leadership at the Helm

Cardium Therapeutics has established a diversified portfolio of medical products with large market potential. Armed with a capital-efficient, asset-based business strategy, the company is positioned to continue to build its portfolio with balanced risk/return opportunities in a variety of markets and is working to secure approval for marketing and sale in South Korea and the European Union.

Company CEO Christopher J. Reinhard founded the company in December 2003, backed by nearly 15 years of focus on the commercial development of cardiovascular growth factor therapeutics.

Under Reinhard’s leadership, Cardium is working to advance its ASPIRE Generx® clinical study at major medical centers in Russia. The company is also seeking clinical development and commercialization partners for Generx® in countries such as India, China and Brazil.

The Generx® product candidate is a minimally invasive DNA-based angiogenic growth factor therapy in development for the treatment of patients with advanced coronary artery disease. The product is being developed for international markets as an alternative treatment for patients who may not have access to surgical revascularization procedures such as coronary artery bypass surgery and angioplasty/stents.

Cardium’s Excellagen® is a syringe-based collagen gel designed to speed the growth of granulation tissue and to trigger the wound healing process. The product is FDA-cleared as treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical wounds, and other dermal wounds. Cardium is seeking commercialization partners for the marketing and sale of the product both domestically and internationally.

Cardium’s To Go Brands® develops, markets, and sells more than 25 products in support of a healthy lifestyle. The product line includes nutraceutical powder mixes, supplements, and chews sold through mass, food, and drug retailers.

Cardium is working to broaden and grow its To Go Brands® nutraceutical supplement brand platform and continues to review acquisitions of other companies and businesses to identify additional product opportunities and technologies.

For more information, visit www.cardiumthx.com

DoMark International, Inc. (DOMK) Successfully Targets Critical Mobile Charging Market

DoMark International seeks out companies offering profitable technologies with proven markets. It’s a term that perfectly describes the company’s primary subsidiary, SolaWerks, serving one of the modern world’s most widespread and expanding markets, mobile devices. SolaWerks sells their own proprietary and superior technology for charging some of the most popular mobile devices. Their systems incorporate a unique system for capturing invisible infrared radiation, allowing Apple and Samsung devices to be charged both indoors and outdoors.

Anyone who questions the importance of mobile device charging need only reflect on events immediately following Superstorm Sandy. For days after the storm, restaurants all over the New York area saw long lines of people, not looking for food but rather electricity. After losing power for so long, they were desperate to charge their mobile phones and tablets. The city is now even putting in place public charging stations to better address this growing need.

The fact is that richly functional mobile communication is increasingly considered a necessity for virtually every corner of society, all of it powered by battery technology requiring a flexible and robust charging resource. The company has already received 158,000 orders for their new IRCharger case for Apple iPhones and Samsung Galaxy smartphones, all prior to their August launch. Given the retail pricing structure for the products, it represents a huge revenue kick for both SolaWerks and DoMark.

For more information, visit www.DoMarkIntl.com

Anthera Pharmaceuticals, Inc. (ANTH) Initiates BRIGHT-SC Phase 2 Clinical Study of Blisibimod for Treating IgA Nephropathy

Biopharmaceutical company Anthera Pharmaceuticals has announced the initiation of the BRIGHT-SC Phase 2 study of blisibimod, which is a novel inhibitor of B-cell activating factor (BAFF) for treating IgA nephropathy. A chronic autoimmune renal disease, IgA nephropathy is characterized by proteinuria and progression to end-stage renal disease.

A multicenter, placebo-controlled, double-blind Phase 2 clinical study, the BRIGHT-SC trial is anticipated to enroll a minimum of 48 patients from Asia Pacific geographies, who will then be randomized into one active treatment arm or one placebo arm. The study’s primary endpoint will be a reduction in proteinuria at 32 weeks. After the patients have completed eight weeks of therapy, Anthera intends to conduct an interim analysis of proteinuria. The study’s secondary endpoints will include the effects of blisibimod on estimated glomerular filtration rate (eGFR), plasma B cells and other kidney disease biomarkers.

Anthera met with the United States Food and Drug Administration (FDA) in May of this year to discuss the future of the IgA nephropathy development plan. The company has been encouraged by the outcome of its pre-Investigational New Drug meeting with the FDA, and the agency’s reception was positive regarding the use of proteinuria as a primary endpoint in studies of IgA nephropathy. The data from the BRIGHT-SC study design will aid Anthera in its efforts to obtain an accelerated approval for blisibimod in this potential orphan indication.

Anthera will meet with the Japanese Pharmaceutical Medical Devices Agency in the coming weeks to explore development strategies in Japan.

For more information, visit www.anthera.com

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

RedChip
(MEET)

2.

Streetwise Reports
(CLZ)

3.

PennyStocks24
(CLGZF)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251